Regulation of Cardiomyocyte Maturation

心肌细胞成熟的调节

基本信息

  • 批准号:
    9888413
  • 负责人:
  • 金额:
    $ 58.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-15 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Adult cardiomyocytes (CMs) are specialized to forcefully contract and relax billions of times during an animal's lifetime. A number of adaptations allow adult CMs to fulfill this role, including: large, elongated shape; highly organized network of cell-cell junctions; reliance on oxidative metabolism; nearly crystalline array of sarcomeres; characteristic organization of calcium release units around a network of plasma membrane invaginations known as T-tubules; cell cycle exit; and expression of adult CM-specific contractile, calcium handling, and ion channel genes. In mouse, most of these adaptations are acquired in the first three postnatal weeks. Little is known about the molecular regulation of the CM maturation program. This information gap limits development of rational approaches to stimulate maturation of stem-cell derived CMs. Furthermore, it is likely that congenital heart disease mutations or abnormal cardiac stress caused by congenital heart malformations impact CM maturation, with implications for long term myocardial performance of congenital heart disease patients. Our long term goal is to understand the regulatory program that governs CM maturation. Our preliminary data show that GATA4 and GATA6 (GATA4/6) transcription factors are essential for CM maturation. In addition, a forward genetic screen uncovered TAF3, a component of the RNA Polymerase II pre-initiation complex and a reader of H3K4me3 epigenetic marks, as a novel maturation regulators. Using a number of unique and novel tools and approaches, this proposal will investigate mechanisms that control CM maturation. Aim 1 will dissect the mechanisms by which GATA4 and GATA6 regulate enhancer activity during CM maturation. Aim 2 will further characterize TAF3 mutants and dissect the mechanisms by which it regulates maturation. Aim 3 will apply our innovative in vivo forward genetic screen to discover signaling molecules and congenital heart disease genes that are essential for CM maturation. The coordinated transformation of fetal CMs to their mature counterparts is among the least well understood aspects of cardiac development. Success with this proposal's aims will advance our knowledge in this unexplored frontier of cardiac development.
项目摘要/摘要 成年心肌细胞(CMS)专门用于在一年中收缩和松弛数十亿次 动物的一生。许多适应允许成年CMS履行这一角色,包括:大的,拉长的形状; 高度组织的细胞-细胞连接网络;对氧化代谢的依赖;近乎结晶的阵列 肌节.围绕质膜网络的钙释放单元的特征组织 T管内陷;细胞周期退出;成体CM特异性收缩钙的表达 操控和离子通道基因。在小鼠中,这些适应大多是在出生后的前三个月获得的 几周。对CM成熟程序的分子调控知之甚少。这种信息鸿沟 限制了刺激干细胞来源的CMS成熟的合理方法的发展。此外,它是 很可能是先天性心脏病突变或由先天性心脏病引起的异常心脏应激 畸形对心肌成熟的影响及其对先天性心肌长期表现的影响 心脏病患者。 我们的长期目标是了解管理CM成熟的监管计划。我们的 初步数据表明,GATA4和GATA6(GATA4/6)转录因子是CM的必需转录因子 成熟。此外,正向遗传筛查发现了RNA聚合酶II的一个组成部分TAF3 预启动复合体和阅读器H3K4me3的表观遗传标记,作为一种新的成熟调节因子。使用 许多独特和新颖的工具和方法,本提案将调查控制CM的机制 成熟。目标1将剖析GATA4和GATA6调节增强子活性的机制 Cm成熟。目标2将进一步描述TAF3突变体的特征,并剖析其调节机制 成熟。AIM 3将应用我们创新的体内正向遗传筛查来发现信号分子和 先天性心脏病基因是CM成熟所必需的。 胎儿CMS向成熟CMS的协调转换是最不好的之一 了解心脏发育的各个方面。成功实现该提案的目标将在以下方面提高我们的知识 这是心脏发育的未开发前沿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Tswenching Pu其他文献

William Tswenching Pu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Tswenching Pu', 18)}}的其他基金

Desmosomes in cardiomyocyte homeostasis and disease
桥粒在心肌细胞稳态和疾病中的作用
  • 批准号:
    10606894
  • 财政年份:
    2022
  • 资助金额:
    $ 58.88万
  • 项目类别:
CMYA5 regulation of cardiac dyad structure and function
CMYA5对心脏二元体结构和功能的调节
  • 批准号:
    10607816
  • 财政年份:
    2022
  • 资助金额:
    $ 58.88万
  • 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
  • 批准号:
    10576399
  • 财政年份:
    2021
  • 资助金额:
    $ 58.88万
  • 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
  • 批准号:
    10355481
  • 财政年份:
    2021
  • 资助金额:
    $ 58.88万
  • 项目类别:
Regulation of Cardiomyocyte Maturation
心肌细胞成熟的调节
  • 批准号:
    10334508
  • 财政年份:
    2019
  • 资助金额:
    $ 58.88万
  • 项目类别:
Enabling mammalian in vivo forward genetic screens based on cell morphology
实现基于细胞形态的哺乳动物体内正向遗传筛选
  • 批准号:
    9754850
  • 财政年份:
    2018
  • 资助金额:
    $ 58.88万
  • 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
  • 批准号:
    9751955
  • 财政年份:
    2017
  • 资助金额:
    $ 58.88万
  • 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
  • 批准号:
    9376461
  • 财政年份:
    2017
  • 资助金额:
    $ 58.88万
  • 项目类别:
2015 Weinstein Cardiovaascular Development Conference
2015年韦恩斯坦心血管发展大会
  • 批准号:
    8911591
  • 财政年份:
    2015
  • 资助金额:
    $ 58.88万
  • 项目类别:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
YAP1 对心肌细胞增殖、功能和再生的调节
  • 批准号:
    8412652
  • 财政年份:
    2013
  • 资助金额:
    $ 58.88万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 58.88万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 58.88万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了